title: Myasthenialike syndrome due to adverse effects of cibenzoline in a patient with chronic renal failure.
authors.forename: Y
authors.initials: Y
authors.lastname: Wakutani
authors.forename: E
authors.initials: E
authors.lastname: Matsushima
authors.forename: A
authors.initials: A
authors.lastname: Son
authors.forename: Y
authors.initials: Y
authors.lastname: Shimizu
authors.forename: Y
authors.initials: Y
authors.lastname: Goto
authors.forename: H
authors.initials: H
authors.lastname: Ishida
mesh_terms: D000787:Angina Pectoris / Q000150:complications / Q000188:drug therapy*; D000889:Anti-Arrhythmia Agents / Q000009:adverse effects*; D001145:Arrhythmias, Cardiac / Q000150:complications / Q000188:drug therapy*; D004558:Electric Stimulation; D006352:Heart Ventricles; D006801:Humans; D007093:Imidazoles / Q000009:adverse effects*; D007676:Kidney Failure, Chronic / Q000150:complications* / Q000503:physiopathology / Q000628:therapy; D008297:Male; D008875:Middle Aged; D018482:Muscle, Skeletal / Q000187:drug effects / Q000294:innervation / Q000503:physiopathology*; D009157:Myasthenia Gravis; D010531:Peritoneal Dialysis, Continuous Ambulatory; D014459:Ulnar Nerve / Q000187:drug effects / Q000503:physiopathology
chemical_list: D000889:Anti-Arrhythmia Agents; D007093:Imidazoles; C032151:cifenline